Duygu Uçkan

3.4k total citations
153 papers, 2.1k citations indexed

About

Duygu Uçkan is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Duygu Uçkan has authored 153 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 39 papers in Genetics and 29 papers in Molecular Biology. Recurrent topics in Duygu Uçkan's work include Hematopoietic Stem Cell Transplantation (44 papers), Mesenchymal stem cell research (31 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Duygu Uçkan is often cited by papers focused on Hematopoietic Stem Cell Transplantation (44 papers), Mesenchymal stem cell research (31 papers) and Childhood Cancer Survivors' Quality of Life (13 papers). Duygu Uçkan collaborates with scholars based in Türkiye, United States and Netherlands. Duygu Uçkan's co-authors include Emine Kılıç, Alp Can, Fadıl Kara, Serçin Karahüseyinoğlu, Ajlan Tükün, Duygu Özel Demiralp, Güvem Gümüş‐Akay, Barış Kuşkonmaz, Mualla Çetin and İlhan Tezcan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Scientific Reports.

In The Last Decade

Duygu Uçkan

148 papers receiving 2.1k citations

Peers

Countries citing papers authored by Duygu Uçkan

Since Specialization

Citations

This map shows the geographic impact of Duygu Uçkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duygu Uçkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duygu Uçkan more than expected).

Fields of papers citing papers by Duygu Uçkan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Duygu Uçkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duygu Uçkan. The network helps show where Duygu Uçkan may publish in the future.

Co-authorship network of co-authors of Duygu Uçkan

This figure shows the co-authorship network connecting the top 25 collaborators of Duygu Uçkan. A scholar is included among the top collaborators of Duygu Uçkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Duygu Uçkan. Duygu Uçkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Detailed characterization of bone marrow adipose tissue mesenchymal stem cells in healthy donor, Fanconi anemia, and acute myeloid leukemia 2025 ·Bone ·(unknown), (unknown), Cemil Can Eylem, Tuba Reçber, Emirhan Nemutlu, (unknown), İbrahim Vargel, Duygu Uçkan	1
2	The Outcome of Modified St. Jude Total XV Protocol in Turkish Children with Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis 2024 ·Turkish Journal of Hematology ·Hülya Yılmaz, Selin Aytaç, Barış Kuşkonmaz, Duygu Uçkan, Şule Ünal, Fatma Gümrük	0
3	Combined immunodeficiency due to purine nucleoside phosphorylase deficiency: Outcome of three patients 2022 ·European Journal of Medical Genetics ·(unknown), (unknown), Dıclehan Orhan, Rahşan Göçmen, (unknown), Barış Kuşkonmaz, Duygu Uçkan, İlhan Tezcan, Deniz Çağdaş	11
4	Intestinal mycobiota composition and changes in children with thalassemia who underwent allogeneic hematopoietic stem cell transplantation 2021 ·Pediatric Blood & Cancer ·Sıddika Songül Yalçın, (unknown), Barış Kuşkonmaz, Namık Yaşar Özbek, Vicente Pérez‐Brocal, Melda Çelik, Duygu Uçkan, Andrés Moyá, Ener Çağrı Dinleyici	3
5	Effect of a Decellularized Omentum Scaffold with Combination of Mesenchymal Stem Cells and Platelet-Rich Plasma on Healing of Critical-Sized Bone Defect: A Rat Model 2021 ·Applied Sciences ·(unknown), (unknown), Duygu Uçkan, Emine Kılıç, (unknown), (unknown), Egemen Turhan	5
6	Characterization of human bone marrow niches with metabolome and transcriptome profiling 2021 ·Journal of Cell Science ·Selda Ayhan, Emirhan Nemutlu, Duygu Uçkan, Sedef Kır, Rıza Köksal Özgül	3
7	Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges 2021 ·Advances in experimental medicine and biology ·Sevil Köse, Fatima Aerts‐Kaya, Duygu Uçkan, Petek Korkusuz	5
8	Osteopetrotic induced pluripotent stem cells derived from patients with different disease-associated mutations by non-integrating reprogramming methods 2019 ·Stem Cell Research & Therapy ·Fatma Visal Okur, (unknown), (unknown), Çetin Kocaefe, Duygu Uçkan	12
9	Bone marrow mesenchymal stem cell donors with a high body mass index display elevated endoplasmic reticulum stress and are functionally impaired 2018 ·Journal of Cellular Physiology ·(unknown), (unknown), (unknown), Günay Balta, Barış Kuşkonmaz, Duygu Uçkan, Fatima Aerts‐Kaya	34
10	Additive effect of mesenchymal stem cells and defibrotide in an arterial rat thrombosis model 2017 ·Archivos Argentinos de Pediatria ·Dílek Díllí, Emine Kılıç, Nıhat Yumuşak, Serdar Beken, Duygu Uçkan, Ramazan Karabulut, (unknown)	3
11	Hypothermic storage of hematopoetic stem cells can be used as an alternative to short-term cryopreservation 2017 ·Experimental Hematology ·(unknown), (unknown), Duygu Uçkan, Gerard Wagemaker, Fatima Aerts‐Kaya	1
12	Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production 2017 ·Stem Cell Reviews and Reports ·(unknown), (unknown), Fatima Aerts‐Kaya, Najim Ameziane, Barış Kuşkonmaz, Josephine C. Dorsman, Fatma Gümrük, Duygu Uçkan	9
13	Effect of Ocimum basilicum on mesenchymal stem cell proliferation and differentiation: Does the effect change according to niches? 2017 ·International Journal of Secondary Metabolite ·(unknown), (unknown), Nurdan Saraç, (unknown), (unknown), Duygu Uçkan	7
14	Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation 2017 ·Experimental Hematology ·Sevil Köse, Fatima Aerts‐Kaya, (unknown), Emirhan Nemutlu, Barış Kuşkonmaz, (unknown), Ekim Z. Taşkıran, Belgin Altun, Duygu Uçkan, Petek Korkusuz	30
15	Successful treatment of severe myasthenia gravis developed after allogeneic hematopoietic stem cell transplantation with plasma exchange and rituximab 2013 ·Pediatric Blood & Cancer ·Şule Ünal, Erdal Sağ, Barış Kuşkonmaz, Selman Kesici, Benan Bayrakçı, Deniz Çağdaş, İlhan Tezcan, Dilek Yalnızoğlu, Duygu Uçkan	12
16	Bone Marrow Mesenchymal Stem Cells in Patients with Beta Thalassemia Major: Molecular Analysis with Attenuated Total Reflection-Fourier Transform Infrared Spectroscopy Study as a Novel Method 2012 ·Stem Cells and Development ·(unknown), (unknown), Emine Kılıç, Duygu Uçkan, Feride Severcan	25
17	A novel mutation in a family with DNA ligase IV deficiency syndrome 2009 ·Pediatric Blood & Cancer ·Şule Ünal, Karen Cerosaletti, Duygu Uçkan, Mualla Çetin, Fatma Gümrük	24
18	CD‐34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia 2007 ·Pediatric Blood & Cancer ·Yasemin Işık Balcı, (unknown), Fatma Gümrük, Mualla Çetin, Fikret Arpacı, Duygu Uçkan	7
19	Long-term survival in severe combined immune deficiency: The role of persistent maternal engraftment 2005 ·The Journal of Pediatrics ·İlhan Tezcan, Fügen Ersoy, Özden Sanal, Tuba Turul, Duygu Uçkan, Sevim Balcı, Gönül Hiçsönmez, (unknown), (unknown), (unknown)	13
20	Pneumatosis intestinalis in an infant undergoing bone marrow transplantation for Wiskott–Aldrich syndrome 2001 ·Pediatric Transplantation ·Duygu Uçkan, Mualla Çetin, (unknown), Arbay Ö. Çiftçi, Murat Tuncer, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact